ST Pharm Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ST Pharm Co Ltd with three other
pharmaceutical manufacturers in Asia:
Suven Life Sciences Limited
of India
(2018
sales of 6.25 billion Indian Rupees [US$87.60 million]
of which 95%
was Intermediaries under Contract Research/M),
Morepen Laboratories Limited
of India
(6.07 billion Indian Rupees [US$84.97 million]
of which 100%
was Pharmaceuticals), and
Astrazeneca Pharma India Ltd
which is
also
based in India
(5.71 billion Indian Rupees [US$80.00 million]
).
Sales Analysis.
ST Pharm Co Ltd reported sales of 97.74 billion Korean Won (US$86.79 million)
for the
year ending
December of 2018.
This
represents
a
sharp
decrease of 51.8%
versus 2017, when the company's sales were 202.80 billion Korean Won.